TrialBMC cancer2016

Long-term use of lenalidomide and low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: MM-024 Extended Access Program.

Xin Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.